| Active Not Recruiting | PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2023-10-16 |
| Completed | Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type Irritable Bowel Syndrome of Diarrhea Type (IBS-D) | Phase 2 | 2023-08-02 |
| Completed | To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patient Atopic Dermatitis (AD) | Phase 3 | 2023-02-17 |
| Completed | To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD Atopic Dermatitis (AD) | Phase 3 | 2023-02-06 |
| Completed | Safety and Tolerability, and PK of Sibeprenlimab in Chinese Healthy Subject Healthy Subjects (HS) | Phase 1 | 2022-10-18 |
| Completed | OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects Open Angle Glaucoma or Ocular Hypertension | Phase 3 | 2022-09-27 |
| Completed | OPC-61815 in Healthy Chinese Male Subjects Healthy Adult Male | Phase 1 | 2022-06-30 |
| Active Not Recruiting | The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | 2020-07-09 |
| Completed | Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia Schizophrenia | Phase 3 | 2019-11-27 |
| Completed | The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects Healthy | Phase 1 | 2019-04-24 |
| Completed | The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects Health | Phase 1 | 2019-04-07 |
| Completed | PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia Schizophrenia | Phase 1 | 2018-08-17 |
| Terminated | The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder Major Depressive Disorder | Phase 3 | 2018-05-30 |
| Completed | Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome Tourette Syndrome | Phase 3 | 2018-05-02 |
| Completed | Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder Autistic Disorder | Phase 3 | 2018-04-09 |
| Completed | Aripiprazole IM Depot for Chinese Patients With Schizophrenia Schizophrenia | Phase 1 | 2017-06-23 |
| Completed | Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia Schizophrenia | Phase 3 | 2017-05-15 |
| Completed | To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment Severe Hypercholesterolemia | Phase 4 | 2013-10-01 |
| Completed | Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema Cardiac Edema | Phase 3 | 2012-07-01 |
| Completed | Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects Healthy | Phase 1 | 2012-02-01 |
| Completed | Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol Health Subjects | Phase 1 | 2011-06-16 |
| Completed | Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male Healthy Subjects | Phase 1 | 2011-06-07 |
| Completed | Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia Hyperlipidemia | Phase 3 | 2011-04-01 |
| Completed | Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites Ascites, Hepatic Cirrhosis | Phase 3 | 2010-10-01 |
| Completed | A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients Wit Diabetic Nephropathy | Phase 4 | 2010-03-01 |
| Completed | Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors Malignant Solid Tumour | Phase 1 | 2009-12-01 |
| Completed | Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites Ascites, Hepatic Cirrhosis | Phase 2 | 2009-04-01 |
| Completed | Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis Hepatic Cirrhosis, Ascites | Phase 1 | 2009-04-01 |
| Completed | Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atheroscleros Atherosclerosis Cerebral Infarction | Phase 4 | 2009-03-01 |
| Completed | A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed Chinese Healthy Volunteers | N/A | 2009-03-01 |
| Completed | Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker Type 2 Diabetes Mellitus, Arteriosclerosis Obliterans | Phase 4 | 2008-10-01 |
| Completed | A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hypona Hypovolemic Hyponatremia | Phase 2 | 2008-05-01 |
| Completed | Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma Non-Hodgkin's Lymphoma(NHL), Multiple Myeloma | Phase 1 | 2007-12-01 |
| Completed | a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects Health Subjects | Phase 1 | 2006-10-01 |
| Completed | Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia Schizophrenia | Phase 2 | 2005-02-01 |
| Completed | Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke Cerebral Infarction | Phase 3 | 2004-05-01 |